(Reuters) - U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

Florricks Lifecare Private Limited, a leading research-driven global pharmaceutical company renowned for its innovative R & D ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed.

We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

Trump previously met with Ubl and chief executives of U.S. drugmakers Pfizer and Eli Lilly at his Mar-a-Lago estate in Florida in December.

The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...